Anson Funds Management LP

Position in TNYA — Tenaya Therapeutics, Inc.

CIK 1491072 DALLAS, TX

Position in TNYA

as of Dec 31, 2025 · filed Feb 17, 2026 Compact

Position Value

$2,956,911

New position

Shares Held

4,152,966

first reported quarter

Ownership

1.91%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Anson Funds Management LP holds $3,211,607 across 3 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	SLNO	Soleno Therapeutics Inc	44,231	$1,480,853
2	SPRO	Spero Therapeutics, Inc.	421,956	$987,377
3	VYNE	VYNE Therapeutics Inc.	1,243,106	$743,377

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$2,956,911	4,152,966	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.